Fitur visualisasi ini dikembangkan menggunakan pendekatan Graph Theory untuk memetakan hubungan polifarmasi dan molekuler. Entitas (Obat, Target, Gen) direpresentasikan sebagai Simpul (Nodes), sedangkan hubungan biologisnya sebagai Sisi (Edges).
drugbank-id dan name pada skema XML DrugBank.targets/target yang memuat polipeptida sasaran.gene-name dan varian snp-effects.Tata letak grafik menggunakan algoritma Force-Directed Graph (Barnes-Hut). Model fisika ini menerapkan gaya tolak-menolak antar simpul (Gravitasi: -3000) agar tidak tumpang tindih, serta gaya pegas (Spring: 0.04) pada garis penghubung untuk fleksibilitas interaksi.
| Buprenorphine | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Buprenorphine. |
| Doxylamine | Doxylamine may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Dronabinol | Dronabinol may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Droperidol | Droperidol may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Hydrocodone | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Hydrocodone. |
| Hydroxyzine | Hydroxyzine may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Magnesium sulfate | The therapeutic efficacy of Dixyrazine can be increased when used in combination with Magnesium sulfate. |
| Methotrimeprazine | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Methotrimeprazine. |
| Minocycline | Minocycline may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Mirtazapine | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Mirtazapine. |
| Nabilone | Nabilone may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Orphenadrine | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Orphenadrine. |
| Paraldehyde | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Paraldehyde. |
| Perampanel | Perampanel may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Pramipexole | Dixyrazine may increase the sedative activities of Pramipexole. |
| Ropinirole | Dixyrazine may increase the sedative activities of Ropinirole. |
| Rotigotine | Dixyrazine may increase the sedative activities of Rotigotine. |
| Rufinamide | The risk or severity of adverse effects can be increased when Rufinamide is combined with Dixyrazine. |
| Sodium oxybate | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Sodium oxybate. |
| Suvorexant | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Suvorexant. |
| Tapentadol | Tapentadol may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Thalidomide | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Thalidomide. |
| Zolpidem | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Zolpidem. |
| Amisulpride | Dixyrazine may increase the antipsychotic activities of Amisulpride. |
| Methylphenidate | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Methylphenidate. |
| Dexmethylphenidate | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Dexmethylphenidate. |
| Metoclopramide | The risk or severity of adverse effects can be increased when Metoclopramide is combined with Dixyrazine. |
| Quinagolide | The therapeutic efficacy of Quinagolide can be decreased when used in combination with Dixyrazine. |
| Sulpiride | Dixyrazine may increase the antipsychotic activities of Sulpiride. |
| Methadone | The risk or severity of adverse effects can be increased when Methadone is combined with Dixyrazine. |
| Lithium citrate | Lithium citrate may increase the neurotoxic activities of Dixyrazine. |
| Lithium hydroxide | Lithium hydroxide may increase the neurotoxic activities of Dixyrazine. |
| Mequitazine | Dixyrazine may increase the arrhythmogenic activities of Mequitazine. |
| Tetrabenazine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Tetrabenazine. |
| Deutetrabenazine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Deutetrabenazine. |
| Thiopental | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Thiopental. |
| Metyrosine | The risk or severity of extrapyramidal symptoms and CNS depression can be increased when Metyrosine is combined with Dixyrazine. |
| Ethanol | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Ethanol. |
| Azelastine | Dixyrazine may increase the central nervous system depressant (CNS depressant) activities of Azelastine. |
| Brimonidine | Brimonidine may increase the central nervous system depressant (CNS depressant) activities of Dixyrazine. |
| Zimelidine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Zimelidine. |
| Dapoxetine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Dapoxetine. |
| Seproxetine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Seproxetine. |
| Fluvoxamine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Fluvoxamine. |
| Citalopram | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Citalopram. |
| Duloxetine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Duloxetine. |
| Trazodone | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Trazodone. |
| Paroxetine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Paroxetine. |
| Sertraline | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Sertraline. |
| Sibutramine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Sibutramine. |
| Nefazodone | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Nefazodone. |
| Escitalopram | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Escitalopram. |
| Milnacipran | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Milnacipran. |
| Desvenlafaxine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Desvenlafaxine. |
| Levomilnacipran | The risk or severity of adverse effects can be increased when Levomilnacipran is combined with Dixyrazine. |
| Indalpine | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Indalpine. |
| Ritanserin | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Ritanserin. |
| Alaproclate | The risk or severity of adverse effects can be increased when Dixyrazine is combined with Alaproclate. |
| Esmolol | The serum concentration of Esmolol can be increased when it is combined with Dixyrazine. |
| Betaxolol | The serum concentration of Betaxolol can be increased when it is combined with Dixyrazine. |
| Metoprolol | The serum concentration of Metoprolol can be increased when it is combined with Dixyrazine. |
| Atenolol | The serum concentration of Atenolol can be increased when it is combined with Dixyrazine. |
| Timolol | The serum concentration of Timolol can be increased when it is combined with Dixyrazine. |
| Sotalol | The serum concentration of Sotalol can be increased when it is combined with Dixyrazine. |
| Propranolol | The serum concentration of Propranolol can be increased when it is combined with Dixyrazine. |
| Labetalol | The serum concentration of Labetalol can be increased when it is combined with Dixyrazine. |
| Bisoprolol | The serum concentration of Bisoprolol can be increased when it is combined with Dixyrazine. |
| Alprenolol | The serum concentration of Alprenolol can be increased when it is combined with Dixyrazine. |
| Pindolol | The serum concentration of Pindolol can be increased when it is combined with Dixyrazine. |
| Carvedilol | The serum concentration of Carvedilol can be increased when it is combined with Dixyrazine. |
| Propafenone | The serum concentration of Propafenone can be increased when it is combined with Dixyrazine. |
| Acebutolol | The serum concentration of Acebutolol can be increased when it is combined with Dixyrazine. |
| Nadolol | The serum concentration of Nadolol can be increased when it is combined with Dixyrazine. |
| Bevantolol | The serum concentration of Bevantolol can be increased when it is combined with Dixyrazine. |
| Practolol | The serum concentration of Practolol can be increased when it is combined with Dixyrazine. |
| Penbutolol | The serum concentration of Penbutolol can be increased when it is combined with Dixyrazine. |
| Oxprenolol | The serum concentration of Oxprenolol can be increased when it is combined with Dixyrazine. |
| Dexpropranolol | The serum concentration of Dexpropranolol can be increased when it is combined with Dixyrazine. |
| Celiprolol | The serum concentration of Celiprolol can be increased when it is combined with Dixyrazine. |
| Nebivolol | The serum concentration of Nebivolol can be increased when it is combined with Dixyrazine. |
| Bufuralol | The serum concentration of Bufuralol can be increased when it is combined with Dixyrazine. |
| Bopindolol | The serum concentration of Bopindolol can be increased when it is combined with Dixyrazine. |
| Bupranolol | The serum concentration of Bupranolol can be increased when it is combined with Dixyrazine. |
| Indenolol | The serum concentration of Indenolol can be increased when it is combined with Dixyrazine. |
| Arotinolol | The serum concentration of Arotinolol can be increased when it is combined with Dixyrazine. |
| Levobetaxolol | The serum concentration of Levobetaxolol can be increased when it is combined with Dixyrazine. |
| Talinolol | The serum concentration of Talinolol can be increased when it is combined with Dixyrazine. |
| Anisodamine | The serum concentration of Anisodamine can be increased when it is combined with Dixyrazine. |
| Bucindolol | The serum concentration of Bucindolol can be increased when it is combined with Dixyrazine. |
| Esatenolol | The serum concentration of Esatenolol can be increased when it is combined with Dixyrazine. |
| Cloranolol | The serum concentration of Cloranolol can be increased when it is combined with Dixyrazine. |
| Mepindolol | The serum concentration of Mepindolol can be increased when it is combined with Dixyrazine. |
| Epanolol | The serum concentration of Epanolol can be increased when it is combined with Dixyrazine. |
| Tertatolol | The serum concentration of Tertatolol can be increased when it is combined with Dixyrazine. |
| Landiolol | The serum concentration of Landiolol can be increased when it is combined with Dixyrazine. |
| Morphine | The risk or severity of hypotension and CNS depression can be increased when Dixyrazine is combined with Morphine. |
| Codeine | The risk or severity of hypotension and CNS depression can be increased when Dixyrazine is combined with Codeine. |
| Hydromorphone | The risk or severity of hypotension and CNS depression can be increased when Dixyrazine is combined with Hydromorphone. |
| Meperidine | The risk or severity of hypotension and CNS depression can be increased when Dixyrazine is combined with Meperidine. |
| Oxycodone | The risk or severity of hypotension and CNS depression can be increased when Dixyrazine is combined with Oxycodone. |